IART Integra LifeSciences Holdings Corporation

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024

PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the  following the call.

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit .

Investor Relations:

Chris Ward

(609) 772-7736

   

Media Contact:

Laurene Isip

(609) 208-8121

 

Integra LifeSciences Holdings Corporation



EN
14/10/2024

Underlying

IARTIntegra LifeSciences Holdings Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE
Free
IART Integra LifeSci...

Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to ...

Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research The health economic analysis, conducted in five European countries, shows that hospitals can reduce costs of cerebrospinal fluid leaks after posterior cranial fossa surgeries by using DuraSeal dural sealant instead of fibrin glue PRINCETON, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, today announced the publication of a new economic study, “PEG hydrogel sealant versus fibrin g...

November 13, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Reports Third Quarter 2024 Financial Results

Integra LifeSciences Reports Third Quarter 2024 Financial Results PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2024. Third Quarter 2024 Highlights Third quarter revenues of $380.8 million decreased 0.4% on a reported basis and 8.6% on an organic basis compared to the prior year. Revenue decreased 10.3% on an organic basis excluding Boston.Third quarter GAAP earnings per diluted share of $(0.14), compared to $0.24 in the prior year; adjusted ...

November 4, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Announces Appointment of Mojdeh Poul as President...

Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer A proven healthcare executive with deep global expertise and a distinguished record in business strategy and execution, portfolio transformation, value-creating innovation, commercial excellence, and leadership development PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:IART), a leading global medical technology company, today announced that its board of directors has appointed Mojdeh Poul as the new president and chief executive officer, effective January 6, 2025. Ms. Poul wil...

November 4, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conf...

Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 PRINCETON, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release third quarter 2024 financial results on Monday, November 4, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-...

October 14, 2024 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Heal...

Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference PRINCETON, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the Morgan Stanley Healthcare conference on September 6, 2024 at 10:45am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatm...

September 4, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch